Article
Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension.
Vascular pharmacology - 1 Aug 2016
Happé C M, Szulcek R, Voelkel N F, Bogaard H J
Abstract excerpt
In pulmonary arterial hypertension (PAH) structural and functional abnormalities of the small lung vessels interact and lead to a progressive increase in pulmonary vascular resistance and right heart failure. A current pathobiological concept characterizes PAH as a 'quasi-malignant' disease focusing on cancer-like alterations in endothelial cells (EC) and the importance of their acquired apoptosis-resistant,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
